Endo Tech Minutes 2015-05-08: Difference between revisions
Jump to navigation
Jump to search
Created page with "Date, Time：May.08, 2015 23:00-23:30 JST Location：Teleconference (WebEx meeting) Attendee： Masao Murata, Goro Miura (Fuji Film Co.Ltd.), Katsuya Watanabe (JAHIS/Panaso..." |
mNo edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
Masao Murata, Goro Miura (Fuji Film Co.Ltd.), Katsuya Watanabe (JAHIS/Panasonic Healthcare Co.Ltd.), Hideto Yokoi (Kagawa Univ.), Joe, Atsushi Amano (JAHIS) | Masao Murata, Goro Miura (Fuji Film Co.Ltd.), Katsuya Watanabe (JAHIS/Panasonic Healthcare Co.Ltd.), Hideto Yokoi (Kagawa Univ.), Joe, Atsushi Amano (JAHIS) | ||
[https://docs.google.com/spreadsheets/d/1Qpi2FVmwT77uXLcBzrF22_cx_jcuDlVQFf-CWcBjNR8/edit?usp=sharing Rosters Link] | |||
１． Public Comment discussion | １． Public Comment discussion | ||
- Public comments and action proposal was explained by Art. | - Public comments and action proposal was explained by Art. | ||
- One recommendation to add reason why the ERPO is new by Dr.Yokoi. The words “because the future discussion with pathology domain may interrupt the profile” are added to J-5 description. | - One recommendation to add reason why the ERPO is new by Dr.Yokoi. | ||
- Voting was conducted and all the participants accept this draft and determined to post them to public comment phase. | The words “because the future discussion with pathology domain may interrupt the profile” | ||
are added to J-5 description. | |||
- Voting was conducted and all the participants accept this draft and determined to post | |||
them to public comment phase. | |||
End of the Documentation | End of the Documentation | ||
Latest revision as of 21:23, 7 September 2015
Date, Time：May.08, 2015 23:00-23:30 JST
Location：Teleconference (WebEx meeting)
Attendee：
Masao Murata, Goro Miura (Fuji Film Co.Ltd.), Katsuya Watanabe (JAHIS/Panasonic Healthcare Co.Ltd.), Hideto Yokoi (Kagawa Univ.), Joe, Atsushi Amano (JAHIS)
１． Public Comment discussion
- Public comments and action proposal was explained by Art. - One recommendation to add reason why the ERPO is new by Dr.Yokoi. The words “because the future discussion with pathology domain may interrupt the profile” are added to J-5 description. - Voting was conducted and all the participants accept this draft and determined to post them to public comment phase.
End of the Documentation